# Ocular Availability in Human Tears After Topical Administration of 1.5% Levofloxacin Compared to Active Comparators

> **NCT00703313** · PHASE4 · COMPLETED · sponsor: **Santen Inc.** · enrollment: 72 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** 1.5% levofloxacin ophthalmic solution
- **DRUG:** 0.5% moxifloxacin hydrochloride ophthalmic solution
- **DRUG:** 0.3% gatifloxacin ophthalmic solution

## Key facts

- **NCT ID:** NCT00703313
- **Lead sponsor:** Santen Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2008-06
- **Final completion:** —
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2009-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00703313

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00703313, "Ocular Availability in Human Tears After Topical Administration of 1.5% Levofloxacin Compared to Active Comparators". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00703313. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*